Cryo Cell International (CCEL) Equity Average: 2011-2025
Historic Equity Average for Cryo Cell International (CCEL) over the last 15 years, with Q3 2025 value amounting to -$15.2 million.
- Cryo Cell International's Equity Average fell 4970.94% to -$15.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$15.2 million, marking a year-over-year decrease of 4970.94%. This contributed to the annual value of -$12.1 million for FY2024, which is 9312.0% down from last year.
- Per Cryo Cell International's latest filing, its Equity Average stood at -$15.2 million for Q3 2025, which was down 4970.94% from -$15.1 million recorded in Q2 2025.
- Cryo Cell International's 5-year Equity Average high stood at $4.5 million for Q4 2021, and its period low was -$15.2 million during Q3 2025.
- Its 5-year average for Equity Average is -$4.2 million, with a median of -$2.0 million in 2022.
- Per our database at Business Quant, Cryo Cell International's Equity Average surged by 29346.62% in 2022 and then crashed by 222124.09% in 2024.
- Over the past 5 years, Cryo Cell International's Equity Average (Quarter) stood at $4.5 million in 2021, then plummeted by 143.52% to -$2.0 million in 2022, then crashed by 182.55% to -$5.5 million in 2023, then crashed by 106.16% to -$11.4 million in 2024, then tumbled by 33.44% to -$15.2 million in 2025.
- Its last three reported values are -$15.2 million in Q3 2025, -$15.1 million for Q2 2025, and -$13.9 million during Q1 2025.